墨西哥队列中神经内分泌肿瘤表现为重叠表型与多样遗传缺陷
研究对92例墨西哥成人神经内分泌肿瘤(NEN)患者进行53基因二代测序或Sanger测序,17.4%检出致病或可能致病变异,且这些患者发病年龄显著更年轻;家族性疾病患者携带P/LP变异的比例高于散发病例。
要点
- 92例NEN患者中17.4%检出致病/可能致病变异。
- 携带P/LP变异者发病年龄显著低于其余患者(29.6±10.7 vs 40[21.5-51.5]岁,P=.0384)。
- 家族性疾病患者P/LP变异比例高于散发病例(26.7% vs 8.5%,P=.0282)。
核心结论
- 17.4%的NEN个体检出致病或可能致病变异,研究提供了此前未被表征人群中NEN驱动基因的图谱。
研究设计与样本
- 对墨西哥成人NEN患者血液DNA采用定制的53基因二代测序面板(n=90)或Sanger测序(n=2)进行分析,识别单核苷酸变异、插入缺失和结构变异并进行分类和正交确认,条件允许时对肿瘤样本及额外家庭成员血液DNA行Sanger测序。
主要发现
- 共纳入92例先证者(70.7%女性,51.5%散发性),16例携带致病或可能致病变异,其发病年龄显著低于其余患者(29.6±10.7 vs 40[21.5-51.5]岁,P=.0384)。
- 在Von Hippel Lindau综合征病例中四分之三、多发性内分泌腺瘤病(MEN)1型中三分之一、早发性肢端肥大症/巨人症中四分之一以及库欣病、MEN2A和甲状腺髓样癌的个别病例中鉴定出可能的驱动变异。
- 发现1例临床MEN1伴SDHA变异患者和1例垂体瘤伴神经纤维瘤病1型患者。
- 家族性疾病先证者携带P/LP变异的可能性高于散发病例(26.7% vs 8.5%,P=.0282)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Genetic tests are part of the routine clinical approach to syndromic and nonsyndromic phenotypes of neuroendocrine neoplasms (NENs). Current data on phenotype-genotype associations in NENs, however, do not accurately represent all populations. OBJECTIVE: To describe the frequency, inventory, and clinical associations of germline defects associated with multiple types of NENs in a Mexican cohort. METHODS: Blood DNA from Mexican adults with NENs was analyzed with a 53-gene next-generation sequencing panel developed ad hoc (n = 90) or Sanger sequencing (n = 2). Single nucleotide variants, indels, and structural variants were identified, classified, and subjected to orthogonal confirmation. When possible, tumor samples and blood DNA from additional family members were tested using Sanger sequencing. RESULTS: Ninety-two probands (70.7% women, 51.5% sporadic) were included; 16 carried pathogenic or likely pathogenic (P/LP) variants and were significantly younger at disease onset than the rest (29.6 ± 10.7 vs 40 [21.5-51.5] years, P = .0384). Likely driving variants were identified in three-quarters of Von Hippel Lindau syndrome cases, one-third of multiple endocrine neoplasia (MEN) type 1, one-quarter of early-onset acromegaly/gigantism, and individual cases of Cushing's disease, MEN2A, and medullary thyroid carcinoma. One patient with clinical MEN1 associated with an SDHA variant and 1 with a pituitary tumor and neurofibromatosis type 1 were also identified. Probands with familial disease were more likely to carry P/LP variants than sporadic cases (26.7 vs 8.5%, P = .0282). CONCLUSION: P/LP variants were identified in 17.4% of individuals with NENs. Our research provides a view of the landscape of NEN drivers in a population not previously characterized.
引用
- Hernández-Ramírez LC, Ramírez-Rentería C, Rebollar-Vega RG, et al. Overlapping Presentations and Diverse Genetic Defects Characterize Neuroendocrine Neoplasms in a Mexican Cohort. J Clin Endocrinol Metab. 2025. PMID: 39908201. doi:10.1210/clinem/dgaf075
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。